1887

Abstract

There are four dengue virus (DENV) serotypes. Primary infection with one does not confer protective immunity against the others. We have reported previously that the marmoset () is a useful primary DENV infection model. It has been reported that secondary DENV infection with a heterotypic serotype induces viraemia kinetics and antibody responses that differ from those in primary infection. Thus, it is important to determine the utility of the marmoset as a model for secondary DENV infection. Marmosets were infected with heterologous DENV by secondary inoculation, and viraemia kinetics and antibody responses were analysed. The marmosets consistently developed high levels of viraemia after the secondary inoculation with heterologous DENV serotypes. IgM responses were lower compared with primary inoculation responses, whilst IgG responses were rapid and high. Neutralizing activities, which possessed serotype cross-reactive activities, were detected as early as 4 days after inoculation. In addition, infectious viraemia titres were higher when assayed with Fcγ receptor-expressing baby hamster kidney (BHK) cells than when assayed with conventional BHK cells, suggesting the presence of infectious virus–antibody immune complexes. After secondary infection with heterotypic DENV, the marmosets demonstrated viraemia kinetics, IgM and IgG responses, and high levels of serotype cross-reactive neutralizing antibody responses, all of which were consistent with secondary DENV infection in humans. The results indicate the marmoset as a useful animal for studying secondary, as well as primary, DENV infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.060384-0
2014-03-01
2019-11-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/95/3/591.html?itemId=/content/journal/jgv/10.1099/vir.0.060384-0&mimeType=html&fmt=ahah

References

  1. Anantapreecha S. , Chanama S. , A-nuegoonpipat A. , Naemkhunthot S. , Sa-Ngasang A. , Sawanpanyalert P. , Kurane I. . ( 2005; ). Serological and virological features of dengue fever and dengue haemorrhagic fever in Thailand from 1999 to 2002. . Epidemiol Infect 133:, 503–507. [CrossRef] [PubMed]
    [Google Scholar]
  2. Anantapreecha S. , A-Nuegoonpipat A. , Prakrong S. , Chanama S. , Sa-Ngasang A. , Sawanpanyalert P. , Kurane I. . ( 2007; ). Dengue virus cross-reactive hemagglutination inhibition antibody responses in patients with primary dengue virus infection. . Jpn J Infect Dis 60:, 267–270.[PubMed]
    [Google Scholar]
  3. Bente D. A. , Melkus M. W. , Garcia J. V. , Rico-Hesse R. . ( 2005; ). Dengue fever in humanized NOD/SCID mice. . J Virol 79:, 13797–13799. [CrossRef] [PubMed]
    [Google Scholar]
  4. Bernardo L. , Izquierdo A. , Prado I. , Rosario D. , Alvarez M. , Santana E. , Castro J. , Martínez R. , Rodríguez R. . & other authors ( 2008; ). Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2. . Clin Vaccine Immunol 15:, 439–446. [CrossRef] [PubMed]
    [Google Scholar]
  5. Bhatt S. , Gething P. W. , Brady O. J. , Messina J. P. , Farlow A. W. , Moyes C. L. , Drake J. M. , Brownstein J. S. , Hoen A. G. . & other authors ( 2013; ). The global distribution and burden of dengue. . Nature 496:, 504–507. [CrossRef] [PubMed]
    [Google Scholar]
  6. Clark K. B. , Onlamoon N. , Hsiao H. M. , Perng G. C. , Villinger F. . ( 2013; ). Can non-human primates serve as models for investigating dengue disease pathogenesis. ? Front Microbiol 4:, 305.[PubMed]
    [Google Scholar]
  7. de Alwis R. , Beltramello M. , Messer W. B. , Sukupolvi-Petty S. , Wahala W. M. P. B. , Kraus A. , Olivarez N. P. , Pham Q. , Brien J. D. . & other authors ( 2011; ). In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. . PLoS Negl Trop Dis 5:, e1188. [CrossRef] [PubMed]
    [Google Scholar]
  8. Gubler D. J. , Rosen L. . ( 1976; ). A simple technique for demonstrating transmission of dengue virus by mosquitoes without the use of vertebrate hosts. . Am J Trop Med Hyg 25:, 146–150.[PubMed]
    [Google Scholar]
  9. Guirakhoo F. , Pugachev K. , Arroyo J. , Miller C. , Zhang Z. X. , Weltzin R. , Georgakopoulos K. , Catalan J. , Ocran S. . & other authors ( 2002; ). Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever–dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates. . Virology 298:, 146–159. [CrossRef] [PubMed]
    [Google Scholar]
  10. Guirakhoo F. , Pugachev K. , Zhang Z. , Myers G. , Levenbook I. , Draper K. , Lang J. , Ocran S. , Mitchell F. . & other authors ( 2004; ). Safety and efficacy of chimeric yellow fever–dengue virus tetravalent vaccine formulations in nonhuman primates. . J Virol 78:, 4761–4775. [CrossRef] [PubMed]
    [Google Scholar]
  11. Guy B. , Barban V. , Mantel N. , Aguirre M. , Gulia S. , Pontvianne J. , Jourdier T. M. , Ramirez L. , Gregoire V. . & other authors ( 2009; ). Evaluation of interferences between dengue vaccine serotypes in a monkey model. . Am J Trop Med Hyg 80:, 302–311.[PubMed]
    [Google Scholar]
  12. Guzman M. G. , Alvarez M. , Halstead S. B. . ( 2013; ). Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. . Arch Virol 158:, 1445–1459. [CrossRef] [PubMed]
    [Google Scholar]
  13. Halstead S. B. , Shotwell H. , Casals J. . Clinical Laboratory Responses to Heterologous Infection ( 1973a; ). Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. . J Infect Dis 128:, 15–22. [CrossRef] [PubMed]
    [Google Scholar]
  14. Halstead S. B. , Casals J. , Shotwell H. , Palumbo N. . ( 1973b; ). Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections. . Am J Trop Med Hyg 22:, 365–374.[PubMed]
    [Google Scholar]
  15. Ito M. , Katakai Y. , Ono F. , Akari H. , Mukai R. Z. , Takasaki T. , Kotaki A. , Kurane I. . ( 2011; ). Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes. . Arch Virol 156:, 1073–1077. [CrossRef] [PubMed]
    [Google Scholar]
  16. Kochel T. J. , Watts D. M. , Gozalo A. S. , Ewing D. F. , Porter K. R. , Russell K. L. . ( 2005; ). Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys. . J Infect Dis 191:, 1000–1004. [CrossRef] [PubMed]
    [Google Scholar]
  17. Koraka P. , Benton S. , van Amerongen G. , Stittelaar K. J. , Osterhaus A. D. . ( 2007a; ). Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques. . Vaccine 25:, 5409–5416. [CrossRef] [PubMed]
    [Google Scholar]
  18. Koraka P. , Benton S. , van Amerongen G. , Stittelaar K. J. , Osterhaus A. D. M. E. . ( 2007b; ). Characterization of humoral and cellular immune responses in cynomolgus macaques upon primary and subsequent heterologous infections with dengue viruses. . Microbes Infect 9:, 940–946. [CrossRef] [PubMed]
    [Google Scholar]
  19. Lubiniecki A. S. , Tarr G. C. . ( 1977; ). Immunological sensitization following inapparent infection with dengue virus type 3 in rhesus monkeys. . Experientia 33:, 330–331. [CrossRef] [PubMed]
    [Google Scholar]
  20. Marchette N. J. , Halstead S. B. , Falkler W. A. Jr , Stenhouse A. , Nash D. . ( 1973; ). Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections. . J Infect Dis 128:, 23–30. [CrossRef] [PubMed]
    [Google Scholar]
  21. Moi M. L. , Lim C. K. , Kotaki A. , Takasaki T. , Kurane I. . ( 2011; ). Detection of higher levels of dengue viremia using FcγR-expressing BHK-21 cells than FcγR-negative cells in secondary infection but not in primary infection. . J Infect Dis 203:, 1405–1414. [CrossRef] [PubMed]
    [Google Scholar]
  22. Moi M. L. , Lim C. K. , Chua K. B. , Takasaki T. , Kurane I. . ( 2012; ). Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcγR-expressing cells. . PLoS Negl Trop Dis 6:, e1536. [CrossRef] [PubMed]
    [Google Scholar]
  23. Moi M. L. , Omatsu T. , Hirayama T. , Nakamura S. , Katakai Y. , Yoshida T. , Saito A. , Tajima S. , Ito M. . & other authors ( 2013; ). Presence of viral genome in urine and development of hematuria and pathological changes in kidneys in common marmoset (Callithrix jacchus) after inoculation with dengue virus. . Pathogens 2:, 357–363. [CrossRef]
    [Google Scholar]
  24. Omatsu T. , Moi M. L. , Hirayama T. , Takasaki T. , Nakamura S. , Tajima S. , Ito M. , Yoshida T. , Saito A. . & other authors ( 2011; ). Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity. . J Gen Virol 92:, 2272–2280. [CrossRef] [PubMed]
    [Google Scholar]
  25. Omatsu T. , Moi M. L. , Takasaki T. , Nakamura S. , Katakai Y. , Tajima S. , Ito M. , Yoshida T. , Saito A. . & other authors ( 2012; ). Changes in hematological and serum biochemical parameters in common marmosets (Callithrix jacchus) after inoculation with dengue virus. . J Med Primatol 41:, 289–296. [CrossRef] [PubMed]
    [Google Scholar]
  26. Onlamoon N. , Noisakran S. , Hsiao H. M. , Duncan A. , Villinger F. , Ansari A. A. , Perng G. C. . ( 2010; ). Dengue virus-induced hemorrhage in a nonhuman primate model. . Blood 115:, 1823–1834. [CrossRef] [PubMed]
    [Google Scholar]
  27. Rothman A. L. . ( 2010; ). Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis. . Curr Top Microbiol Immunol 338:, 83–98.[PubMed]
    [Google Scholar]
  28. Scherer W. F. , Breakenridge F. A. , Dickerman R. W. . ( 1972; ). Cross-protection studies and search for subclinical disease in New World monkeys infected sequentially with different immunologic types of dengue viruses. . Am J Epidemiol 95:, 67–79.[PubMed]
    [Google Scholar]
  29. Scherer W. F. , Russell P. K. , Rosen L. , Casals J. , Dickerman R. W. . ( 1978; ). Experimental infection of chimpanzees with dengue viruses. . Am J Trop Med Hyg 27:, 590–599.[PubMed]
    [Google Scholar]
  30. Schiavetta A. M. , Harre J. G. , Wagner E. , Simmons M. , Raviprakash K. . ( 2003; ). Variable susceptibility of the owl monkey (Aotus nancymae) to four serotypes of dengue virus. . Contemp Top Lab Anim Sci 42:, 12–20.[PubMed]
    [Google Scholar]
  31. Shresta S. , Sharar K. L. , Prigozhin D. M. , Beatty P. R. , Harris E. . ( 2006; ). Murine model for dengue virus-induced lethal disease with increased vascular permeability. . J Virol 80:, 10208–10217. [CrossRef] [PubMed]
    [Google Scholar]
  32. Styer L. M. , Kent K. A. , Albright R. G. , Bennett C. J. , Kramer L. D. , Bernard K. A. . ( 2007; ). Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts. . PLoS Pathog 3:, 1262–1270.[PubMed] [CrossRef]
    [Google Scholar]
  33. Tan G. K. , Ng J. K. , Trasti S. L. , Schul W. , Yip G. , Alonso S. . ( 2010; ). A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice. . PLoS Negl Trop Dis 4:, e672. [CrossRef] [PubMed]
    [Google Scholar]
  34. Vaughn D. W. , Whitehead S. S. , Durbin A. . ( 2008; ). Viral vaccines. . In Vaccines for Biodefense and Emerging and Neglected Diseases, pp. 302–304. Edited by Barrett A. D. T. , Stanberry L. R. . . London:: Academic Press, Elsevier;.
    [Google Scholar]
  35. Weiskopf D. , Yauch L. E. , Angelo M. A. , John D. V. , Greenbaum J. A. , Sidney J. , Kolla R. V. , De Silva A. D. , de Silva A. M. . & other authors ( 2011; ). Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design. . J Immunol 187:, 4268–4279. [CrossRef] [PubMed]
    [Google Scholar]
  36. Whitehead R. H. , Chaicumpa V. , Olson L. C. , Russell P. K. . ( 1970; ). Sequential dengue virus infections in the white-handed gibbon (Hylobates lar). . Am J Trop Med Hyg 19:, 94–102.[PubMed]
    [Google Scholar]
  37. WHO ( 2009; ). Dengue: guidelines for diagnosis, treatment, prevention and control. . http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf.
  38. Xu M. , Hadinoto V. , Appanna R. , Joensson K. , Toh Y. X. , Balakrishnan T. , Ong S. H. , Warter L. , Leo Y. S. . & other authors ( 2012; ). Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes. . J Immunol 189:, 5877–5885. [CrossRef] [PubMed]
    [Google Scholar]
  39. Zompi S. , Harris E. . ( 2012; ). Animal models of dengue virus infection. . Viruses 4:, 62–82. [CrossRef] [PubMed]
    [Google Scholar]
  40. Zompi S. , Harris E. . ( 2013; ). Original antigenic sin in dengue revisited. . Proc Natl Acad Sci U S A 110:, 8761–8762. [CrossRef] [PubMed]
    [Google Scholar]
  41. Zompi S. , Montoya M. , Pohl M. O. , Balmaseda A. , Harris E. . ( 2012; ). Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans. . PLoS Negl Trop Dis 6:, e1568. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.060384-0
Loading
/content/journal/jgv/10.1099/vir.0.060384-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error